{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T07:25:31Z","timestamp":1747034731537},"publisher-location":"Cham","reference-count":77,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030267353"},{"type":"electronic","value":"9783030267360"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-26736-0_11","type":"book-chapter","created":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T00:13:32Z","timestamp":1572048812000},"page":"295-313","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Phage Therapy of Infectious Biofilms: Challenges and Strategies"],"prefix":"10.1007","author":[{"given":"Lu\u00eds D. R.","family":"Melo","sequence":"first","affiliation":[]},{"given":"Diana Priscila","family":"Pires","sequence":"additional","affiliation":[]},{"given":"Rodrigo","family":"Monteiro","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Azeredo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,10,26]]},"reference":[{"issue":"2","key":"11_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4161\/bact.1.2.15845","volume":"1","author":"ST Abedon","year":"2011","unstructured":"Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM (2011) Phage treatment of human infections. Bacteriophage 1(2):66\u201385. https:\/\/doi.org\/10.4161\/bact.1.2.15845","journal-title":"Bacteriophage"},{"issue":"8","key":"11_CR2","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1111\/1462-2920.12100","volume":"15","author":"E Allers","year":"2013","unstructured":"Allers E, Moraru C, Duhaime MB, Beneze E, Solonenko N, Barrero-Canosa J, Amann R, Sullivan MB (2013) Single-cell and population level viral infection dynamics revealed by phage FISH, a method to visualize intracellular and free viruses. Environ Microbiol 15(8):2306\u20132318. https:\/\/doi.org\/10.1111\/1462-2920.12100","journal-title":"Environ Microbiol"},{"issue":"21","key":"11_CR3","doi-asserted-by":"publisher","first-page":"6694","DOI":"10.1128\/aem.01789-14","volume":"80","author":"DR Alves","year":"2014","unstructured":"Alves DR, Gaudion A, Bean JE, Perez Esteban P, Arnot TC, Harper DR, Kot W, Hansen LH, Enright MC, Jenkins AT (2014) Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation. Appl Environ Microbiol 80(21):6694\u20136703. https:\/\/doi.org\/10.1128\/aem.01789-14","journal-title":"Appl Environ Microbiol"},{"key":"11_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00196","volume":"8","author":"DR Alves","year":"2018","unstructured":"Alves DR, Booth SP, Scavone P, Schellenberger P, Salvage J, Dedi C, Thet NT, Jenkins ATA, Waters R, Ng KW, Overall ADJ, Metcalfe AD, Nzakizwanayo J, Jones BV (2018) Development of a high-throughput ex-vivo burn wound model using porcine skin, and its application to evaluate new approaches to control wound infection. Front Cell Infect Microbiol 8:196. https:\/\/doi.org\/10.3389\/fcimb.2018.00196","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"11_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41579-018-0019-y","volume":"16","author":"CR Arciola","year":"2018","unstructured":"Arciola CR, Campoccia D, Montanaro L (2018) Implant infections: adhesion, biofilm formation and immune evasion. Nat Rev Microbiol 16(7):397\u2013409. https:\/\/doi.org\/10.1038\/s41579-018-0019-y","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"11_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/1040841X.2016.1208146","volume":"43","author":"J Azeredo","year":"2017","unstructured":"Azeredo J, Azevedo NF, Briandet R, Cerca N, Coenye T, Costa AR, Desvaux M, Di Bonaventura G, Hebraud M, Jaglic Z, Kacaniova M, Knochel S, Lourenco A, Mergulhao F, Meyer RL, Nychas G, Simoes M, Tresse O, Sternberg C (2017) Critical review on biofilm methods. Crit Rev Microbiol 43(3):313\u2013351. https:\/\/doi.org\/10.1080\/1040841X.2016.1208146","journal-title":"Crit Rev Microbiol"},{"issue":"8","key":"11_CR7","first-page":"16","volume":"61","author":"S Basu","year":"2015","unstructured":"Basu S, Agarwal M, Kumar Bhartiya S, Nath G, Kumar Shukla V (2015) An in vivo wound model utilizing bacteriophage therapy of Pseudomonas aeruginosa biofilms. Ostomy Wound Manage 61(8):16\u201323","journal-title":"Ostomy Wound Manage"},{"issue":"7","key":"11_CR8","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s11274-009-9991-8","volume":"25","author":"MS Bedi","year":"2009","unstructured":"Bedi MS, Verma V, Chhibber S (2009) Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B 5055. World J Microbiol Biotechnol 25(7):1145. https:\/\/doi.org\/10.1007\/s11274-009-9991-8","journal-title":"World J Microbiol Biotechnol"},{"issue":"9","key":"11_CR9","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.tim.2013.06.002","volume":"21","author":"T Bjarnsholt","year":"2013","unstructured":"Bjarnsholt T, Alhede M, Alhede M, Eickhardt-Sorensen SR, Moser C, Kuhl M, Jensen PO, Hoiby N (2013) The in vivo biofilm. Trends Microbiol 21(9):466\u2013474. https:\/\/doi.org\/10.1016\/j.tim.2013.06.002","journal-title":"Trends Microbiol"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/5584_2015_5002","volume":"897","author":"G Brackman","year":"2016","unstructured":"Brackman G, Coenye T (2016) In vitro and in vivo biofilm wound models and their application. Adv Exp Med Biol 897:15\u201332. https:\/\/doi.org\/10.1007\/5584_2015_5002","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"11_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1574-695X.2010.00696.x","volume":"59","author":"L Carson","year":"2010","unstructured":"Carson L, Gorman SP, Gilmore BF (2010) The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli. FEMS Immunol Med Microbiol 59(3):447\u2013455. https:\/\/doi.org\/10.1111\/j.1574-695X.2010.00696.x","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"10","key":"11_CR12","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1139\/w11-078","volume":"57","author":"F Cerca","year":"2011","unstructured":"Cerca F, Trigo G, Correia A, Cerca N, Azeredo J, Vilanova M (2011) SYBR green as a fluorescent probe to evaluate the biofilm physiological state of Staphylococcus epidermidis, using flow cytometry. Can J Microbiol 57(10):850\u2013856. https:\/\/doi.org\/10.1139\/w11-078","journal-title":"Can J Microbiol"},{"issue":"6","key":"11_CR13","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/JCM.37.6.1771-1776.1999","volume":"37","author":"H Ceri","year":"1999","unstructured":"Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A (1999) The calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37(6):1771\u20131776","journal-title":"J Clin Microbiol"},{"issue":"1","key":"11_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168615","volume":"12","author":"WN Chaudhry","year":"2017","unstructured":"Chaudhry WN, Concepcion-Acevedo J, Park T, Andleeb S, Bull JJ, Levin BR (2017) Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms. PLoS One 12(1):e0168615. https:\/\/doi.org\/10.1371\/journal.pone.0168615","journal-title":"PLoS One"},{"issue":"7","key":"11_CR15","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.4315\/0362-028x.jfp-16-393","volume":"80","author":"T Chylkova","year":"2017","unstructured":"Chylkova T, Cadena M, Ferreiro A, Pitesky M (2017) Susceptibility of Salmonella biofilm and planktonic bacteria to common disinfectant agents used in poultry processing. J Food Prot 80(7):1072\u20131079. https:\/\/doi.org\/10.4315\/0362-028x.jfp-16-393","journal-title":"J Food Prot"},{"issue":"10","key":"11_CR16","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.3390\/v6103778","volume":"6","author":"LB Coulter","year":"2014","unstructured":"Coulter LB, McLean RJ, Rohde RE, Aron GM (2014) Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilms. Viruses 6(10):3778\u20133786. https:\/\/doi.org\/10.3390\/v6103778","journal-title":"Viruses"},{"issue":"4","key":"11_CR17","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1128\/aac.50.4.1268-1275.2006","volume":"50","author":"JJ Curtin","year":"2006","unstructured":"Curtin JJ, Donlan RM (2006) Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob Agents Chemother 50(4):1268\u20131275. https:\/\/doi.org\/10.1128\/aac.50.4.1268-1275.2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"11_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138651","volume":"10","author":"M Dalmasso","year":"2015","unstructured":"Dalmasso M, de Haas E, Neve H, Strain R, Cousin FJ, Stockdale SR, Ross RP, Hill C (2015) Isolation of a novel phage with activity against Streptococcus mutans biofilms. PLoS One 10(9):e0138651. https:\/\/doi.org\/10.1371\/journal.pone.0138651","journal-title":"PLoS One"},{"issue":"2","key":"11_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.tim.2008.11.002","volume":"17","author":"RM Donlan","year":"2009","unstructured":"Donlan RM (2009) Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 17(2):66\u201372. https:\/\/doi.org\/10.1016\/j.tim.2008.11.002","journal-title":"Trends Microbiol"},{"issue":"3","key":"11_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/alr.21270","volume":"4","author":"A Drilling","year":"2014","unstructured":"Drilling A, Morales S, Boase S, Jervis-Bardy J, James C, Jardeleza C, Tan NC, Cleland E, Speck P, Vreugde S, Wormald PJ (2014) Safety and efficacy of topical bacteriophage and ethylenediaminetetraacetic acid treatment of Staphylococcus aureus infection in a sheep model of sinusitis. Int Forum Allergy Rhinol 4(3):176\u2013186. https:\/\/doi.org\/10.1002\/alr.21270","journal-title":"Int Forum Allergy Rhinol"},{"issue":"10","key":"11_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047348","volume":"7","author":"EV Dubrovin","year":"2012","unstructured":"Dubrovin EV, Popova AV, Kraevskiy SV, Ignatov SG, Ignatyuk TE, Yaminsky IV, Volozhantsev NV (2012) Atomic force microscopy analysis of the Acinetobacter baumannii bacteriophage AP22 lytic cycle. PLoS One 7(10):e47348. https:\/\/doi.org\/10.1371\/journal.pone.0047348","journal-title":"PLoS One"},{"key":"11_CR22","doi-asserted-by":"publisher","unstructured":"Forti F, Roach DR, Cafora M, Pasini ME, Horner DS, Fiscarelli EV, Rossitto M, Cariani L, Briani F (2018) Design of a broad-range bacteriophage cocktail that reduces Pseudomonas aeruginosa biofilms and treats acute infections in two animal models. Antimicrob Agents Chemother 62(6). https:\/\/doi.org\/10.1128\/aac.02573-17","DOI":"10.1128\/aac.02573-17"},{"issue":"1","key":"11_CR23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1128\/aac.00669-09","volume":"54","author":"W Fu","year":"2010","unstructured":"Fu W, Forster T, Mayer O, Curtin JJ, Lehman SM, Donlan RM (2010) Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother 54(1):397\u2013404. https:\/\/doi.org\/10.1128\/aac.00669-09","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02348","volume":"9","author":"S Gonzalez","year":"2018","unstructured":"Gonzalez S, Fernandez L, Gutierrez D, Campelo AB, Rodriguez A, Garcia P (2018) Analysis of different parameters affecting diffusion, propagation and survival of staphylophages in bacterial biofilms. Front Microbiol 9:2348. https:\/\/doi.org\/10.3389\/fmicb.2018.02348","journal-title":"Front Microbiol"},{"issue":"10","key":"11_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163966","volume":"11","author":"D Gutierrez","year":"2016","unstructured":"Gutierrez D, Hidalgo-Cantabrana C, Rodriguez A, Garcia P, Ruas-Madiedo P (2016) Monitoring in real time the formation and removal of biofilms from clinical related pathogens using an impedance-based technology. PLoS One 11(10):e0163966. https:\/\/doi.org\/10.1371\/journal.pone.0163966","journal-title":"PLoS One"},{"issue":"3","key":"11_CR26","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/femsre\/fux010","volume":"41","author":"CW Hall","year":"2017","unstructured":"Hall CW, Mah TF (2017) Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev 41(3):276\u2013301. https:\/\/doi.org\/10.1093\/femsre\/fux010","journal-title":"FEMS Microbiol Rev"},{"issue":"12","key":"11_CR27","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1128\/AAC.01596-13","volume":"57","author":"M Henry","year":"2013","unstructured":"Henry M, Lavigne R, Debarbieux L (2013) Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections. Antimicrob Agents Chemother 57(12):5961\u20135968. https:\/\/doi.org\/10.1128\/AAC.01596-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"11_CR28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","volume":"35","author":"N Hoiby","year":"2010","unstructured":"Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35(4):322\u2013332. https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.12.011","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"11_CR29","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.3390\/v7082835","volume":"7","author":"AV Holguin","year":"2015","unstructured":"Holguin AV, Rangel G, Clavijo V, Prada C, Mantilla M, Gomez MC, Kutter E, Taylor C, Fineran PC, Barrios AF, Vives MJ (2015) Phage Phi Pan70, a putative temperate phage, controls Pseudomonas aeruginosa in planktonic, biofilm and burn mouse model assays. Viruses 7(8):4602\u20134623. https:\/\/doi.org\/10.3390\/v7082835","journal-title":"Viruses"},{"issue":"1","key":"11_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","volume":"19","author":"P Jault","year":"2019","unstructured":"Jault P, Leclerc T, Jennes S, Pirnay JP, Que YA, Resch G, Rousseau AF, Ravat F, Carsin H, Le Floch R, Schaal JV, Soler C, Fevre C, Arnaud I, Bretaudeau L, Gabard J (2019) Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial. Lancet Infect Dis 19(1):35\u201345. https:\/\/doi.org\/10.1016\/S1473-3099(18)30482-1","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"11_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4161\/bbug.2.1.13657","volume":"2","author":"D Kelly","year":"2011","unstructured":"Kelly D, McAuliffe O, Ross RP, O'Mahony J, Coffey A (2011) Development of a broad-host-range phage cocktail for biocontrol. Bioeng Bugs 2(1):31\u201337. https:\/\/doi.org\/10.4161\/bbug.2.1.13657","journal-title":"Bioeng Bugs"},{"issue":"4","key":"11_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1472-765X.2012.03205.x","volume":"54","author":"D Kelly","year":"2012","unstructured":"Kelly D, McAuliffe O, Ross RP, Coffey A (2012) Prevention of Staphylococcus aureus biofilm formation and reduction in established biofilm density using a combination of phage K and modified derivatives. Lett Appl Microbiol 54(4):286\u2013291. https:\/\/doi.org\/10.1111\/j.1472-765X.2012.03205.x","journal-title":"Lett Appl Microbiol"},{"issue":"8","key":"11_CR33","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1128\/AEM.00096-15","volume":"81","author":"L Khalifa","year":"2015","unstructured":"Khalifa L, Brosh Y, Gelman D, Coppenhagen-Glazer S, Beyth S, Poradosu-Cohen R, Que YA, Beyth N, Hazan R (2015) Targeting Enterococcus faecalis biofilms with phage therapy. Appl Environ Microbiol 81(8):2696\u20132705. https:\/\/doi.org\/10.1128\/AEM.00096-15","journal-title":"Appl Environ Microbiol"},{"issue":"17","key":"11_CR34","doi-asserted-by":"publisher","first-page":"6380","DOI":"10.1128\/AEM.00648-12","volume":"78","author":"S Kim","year":"2012","unstructured":"Kim S, Rahman M, Seol SY, Yoon SS, Kim J (2012) Pseudomonas aeruginosa bacteriophage PA1O requires type IV pili for infection and shows broad bactericidal and biofilm removal activities. Appl Environ Microbiol 78(17):6380\u20136385. https:\/\/doi.org\/10.1128\/AEM.00648-12","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"11_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2174\/138920110790725401","volume":"11","author":"E Kutter","year":"2010","unstructured":"Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, Abedon ST (2010) Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol 11(1):69\u201386","journal-title":"Curr Pharm Biotechnol"},{"issue":"11","key":"11_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/v9110315","volume":"9","author":"Simone Latz","year":"2017","unstructured":"Latz S, Kruttgen A, Hafner H, Buhl EM, Ritter K, Horz HP (2017) Differential effect of newly isolated phages belonging to PB1-like, phiKZ-like and LUZ24-like viruses against multi-drug resistant Pseudomonas aeruginosa under varying growth conditions. Viruses 9(11). https:\/\/doi.org\/10.3390\/v9110315","journal-title":"Viruses"},{"issue":"2","key":"11_CR37","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/pathogens2020288","volume":"2","author":"D Lebeaux","year":"2013","unstructured":"Lebeaux D, Chauhan A, Rendueles O, Beloin C (2013) From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens 2(2):288\u2013356. https:\/\/doi.org\/10.3390\/pathogens2020288","journal-title":"Pathogens"},{"key":"11_CR38","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2217\/fmb-2016-0104","volume":"11","author":"Y Liu","year":"2016","unstructured":"Liu Y, Mi Z, Niu W, An X, Yuan X, Liu H, Wang Y, Feng Y, Huang Y, Zhang X, Zhang Z, Fan H, Peng F, Li P, Tong Y, Bai C (2016) Potential of a lytic bacteriophage to disrupt Acinetobacter baumannii biofilms in vitro. Future Microbiol 11:1383\u20131393. https:\/\/doi.org\/10.2217\/fmb-2016-0104","journal-title":"Future Microbiol"},{"issue":"6","key":"11_CR39","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1128\/AAC.01028-06","volume":"51","author":"CS McVay","year":"2007","unstructured":"McVay CS, Velasquez M, Fralick JA (2007) Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob Agents Chemother 51(6):1934\u20131938. https:\/\/doi.org\/10.1128\/AAC.01028-06","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01024","volume":"7","author":"LD Melo","year":"2016","unstructured":"Melo LD, Veiga P, Cerca N, Kropinski AM, Almeida C, Azeredo J, Sillankorva S (2016) Development of a phage cocktail to control Proteus mirabilis catheter-associated urinary tract infections. Front Microbiol 7:1024. https:\/\/doi.org\/10.3389\/fmicb.2016.01024","journal-title":"Front Microbiol"},{"key":"11_CR41","doi-asserted-by":"publisher","unstructured":"Melo LDR, Franca A, Brandao A, Sillankorva S, Cerca N, Azeredo J (2018) Assessment of Sep1virus interaction with stationary cultures by transcriptional and flow cytometry studies. FEMS Microbiol Ecol 94(10). https:\/\/doi.org\/10.1093\/femsec\/fiy143","DOI":"10.1093\/femsec\/fiy143"},{"issue":"4","key":"11_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/wrr.12056","volume":"21","author":"JJ Mendes","year":"2013","unstructured":"Mendes JJ, Leandro C, Corte-Real S, Barbosa R, Cavaco-Silva P, Melo-Cristino J, Gorski A, Garcia M (2013) Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds. Wound Repair Regen 21(4):595\u2013603. https:\/\/doi.org\/10.1111\/wrr.12056","journal-title":"Wound Repair Regen"},{"issue":"Pt 8","key":"11_CR43","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1099\/jmm.0.071753-0","volume":"63","author":"JJ Mendes","year":"2014","unstructured":"Mendes JJ, Leandro C, Mottola C, Barbosa R, Silva FA, Oliveira M, Vilela CL, Melo-Cristino J, Gorski A, Pimentel M, Sao-Jose C, Cavaco-Silva P, Garcia M (2014) In vitro design of a novel lytic bacteriophage cocktail with therapeutic potential against organisms causing diabetic foot infections. J Med Microbiol 63(Pt 8):1055\u20131065. https:\/\/doi.org\/10.1099\/jmm.0.071753-0","journal-title":"J Med Microbiol"},{"issue":"7","key":"11_CR44","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/08927014.2018.1501475","volume":"34","author":"Catarina Milho","year":"2018","unstructured":"Milho C, Silva MD, Melo L, Santos S, Azeredo J, Sillankorva S (2018) Control of Salmonella Enteritidis on food contact surfaces with bacteriophage PVP-SE2. Biofouling:1\u201316. https:\/\/doi.org\/10.1080\/08927014.2018.1501475","journal-title":"Biofouling"},{"key":"11_CR45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijpharm.2018.12.004","volume":"557","author":"C Milho","year":"2019","unstructured":"Milho C, Andrade M, Vilas Boas D, Alves D, Sillankorva S (2019) Antimicrobial assessment of phage therapy using a porcine model of biofilm infection. Int J Pharm 557:112\u2013123. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.12.004","journal-title":"Int J Pharm"},{"issue":"2","key":"11_CR46","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.foodcont.2011.08.016","volume":"23","author":"VY Montanez-Izquiredo","year":"2012","unstructured":"Montanez-Izquiredo VY, Salas-Vazquez DI, Rodriguez JJ (2012) Use of epifluorescence microscopy to assess the effectiveness of phage P100 in controlling Listeria monocytogenes biofilms on stainless steel surfaces. Food Control 23(2):470\u2013477","journal-title":"Food Control"},{"issue":"1","key":"11_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0923-2508(01)01280-3","volume":"153","author":"T Nakai","year":"2002","unstructured":"Nakai T, Park SC (2002) Bacteriophage therapy of infectious diseases in aquaculture. Res Microbiol 153(1):13\u201318","journal-title":"Res Microbiol"},{"issue":"7","key":"11_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180838","volume":"12","author":"IB Naser","year":"2017","unstructured":"Naser IB, Hoque MM, Abdullah A, Bari SMN, Ghosh AN, Faruque SM (2017) Environmental bacteriophages active on biofilms and planktonic forms of toxigenic Vibrio cholerae: potential relevance in cholera epidemiology. PLoS One 12(7):e0180838. https:\/\/doi.org\/10.1371\/journal.pone.0180838","journal-title":"PLoS One"},{"issue":"3","key":"11_CR49","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1128\/aac.02685-15","volume":"60","author":"J Nzakizwanayo","year":"2015","unstructured":"Nzakizwanayo J, Hanin A, Alves DR, McCutcheon B, Dedi C, Salvage J, Knox K, Stewart B, Metcalfe A, Clark J, Gilmore BF, Gahan CG, Jenkins AT, Jones BV (2015) Bacteriophage can prevent encrustation and blockage of urinary catheters by Proteus mirabilis. Antimicrob Agents Chemother 60(3):1530\u20131536. https:\/\/doi.org\/10.1128\/aac.02685-15","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02407","volume":"8","author":"A Oliveira","year":"2017","unstructured":"Oliveira A, Ribeiro HG, Silva AC, Silva MD, Sousa JC, Rodrigues CF, Melo LDR, Henriques AF, Sillankorva S (2017) Synergistic antimicrobial interaction between honey and phage against Escherichia coli biofilms. Front Microbiol 8:2407. https:\/\/doi.org\/10.3389\/fmicb.2017.02407","journal-title":"Front Microbiol"},{"key":"11_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01725","volume":"9","author":"A Oliveira","year":"2018","unstructured":"Oliveira A, Sousa JC, Silva AC, Melo LDR, Sillankorva S (2018) Chestnut honey and bacteriophage application to control Pseudomonas aeruginosa and Escherichia coli biofilms: evaluation in an ex vivo wound model. Front Microbiol 9:1725. https:\/\/doi.org\/10.3389\/fmicb.2018.01725","journal-title":"Front Microbiol"},{"issue":"17","key":"11_CR52","doi-asserted-by":"publisher","first-page":"5340","DOI":"10.1128\/AEM.01434-14","volume":"80","author":"R Pei","year":"2014","unstructured":"Pei R, Lamas-Samanamud GR (2014) Inhibition of biofilm formation by T7 bacteriophages producing quorum-quenching enzymes. Appl Environ Microbiol 80(17):5340\u20135348. https:\/\/doi.org\/10.1128\/AEM.01434-14","journal-title":"Appl Environ Microbiol"},{"issue":"7","key":"11_CR53","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1128\/AAC.49.7.2612-2617.2005","volume":"49","author":"RK Pettit","year":"2005","unstructured":"Pettit RK, Weber CA, Kean MJ, Hoffmann H, Pettit GR, Tan R, Franks KS, Horton ML (2005) Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Chemother 49(7):2612\u20132617. https:\/\/doi.org\/10.1128\/AAC.49.7.2612-2617.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-4939-7395-8_4","volume":"1693","author":"DP Pires","year":"2018","unstructured":"Pires DP, Melo LDR (2018) In vitro activity of bacteriophages against planktonic and biofilm populations assessed by flow cytometry. Methods Mol Biol 1693:33\u201341. https:\/\/doi.org\/10.1007\/978-1-4939-7395-8_4","journal-title":"Methods Mol Biol"},{"issue":"10","key":"11_CR55","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1080\/08927014.2013.831842","volume":"29","author":"DP Pires","year":"2013","unstructured":"Pires DP, Silva S, Almeida C, Henriques M, Anderson EM, Lam JS, Sillankorva S, Azeredo J (2013) Evaluation of the ability of C. albicans to form biofilm in the presence of phage-resistant phenotypes of P. aeruginosa. Biofouling 29(10):1169\u20131180. https:\/\/doi.org\/10.1080\/08927014.2013.831842","journal-title":"Biofouling"},{"issue":"5","key":"11_CR56","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s00253-015-7247-0","volume":"100","author":"DP Pires","year":"2016","unstructured":"Pires DP, Oliveira H, Melo LD, Sillankorva S, Azeredo J (2016) Bacteriophage-encoded depolymerases: their diversity and biotechnological applications. Appl Microbiol Biotechnol 100(5):2141\u20132151. https:\/\/doi.org\/10.1007\/s00253-015-7247-0","journal-title":"Appl Microbiol Biotechnol"},{"key":"11_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.mib.2017.09.004","volume":"39","author":"DP Pires","year":"2017","unstructured":"Pires DP, Melo L, Vilas Boas D, Sillankorva S, Azeredo J (2017a) Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections. Curr Opin Microbiol 39:48\u201356. https:\/\/doi.org\/10.1016\/j.mib.2017.09.004","journal-title":"Curr Opin Microbiol"},{"key":"11_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01229","volume":"8","author":"DP Pires","year":"2017","unstructured":"Pires DP, Dotsch A, Anderson EM, Hao Y, Khursigara CM, Lam JS, Sillankorva S, Azeredo J (2017b) A genotypic analysis of five P. aeruginosa strains after biofilm infection by phages targeting different cell surface receptors. Front Microbiol 8:1229. https:\/\/doi.org\/10.3389\/fmicb.2017.01229","journal-title":"Front Microbiol"},{"issue":"2","key":"11_CR59","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0167-7012(03)00034-4","volume":"54","author":"B Pitts","year":"2003","unstructured":"Pitts B, Hamilton MA, Zelver N, Stewart PS (2003) A microtiter-plate screening method for biofilm disinfection and removal. J Microbiol Methods 54(2):269\u2013276","journal-title":"J Microbiol Methods"},{"issue":"10","key":"11_CR60","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1080\/08927014.2011.631169","volume":"27","author":"M Rahman","year":"2011","unstructured":"Rahman M, Kim S, Kim SM, Seol SY, Kim J (2011) Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin. Biofouling 27(10):1087\u20131093. https:\/\/doi.org\/10.1080\/08927014.2011.631169","journal-title":"Biofouling"},{"key":"11_CR61","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/978-1-4419-6084-9_16","volume-title":"Biofilm infections","author":"KP Rumbaugh","year":"2011","unstructured":"Rumbaugh KP, Carty NL (2011) In vivo models of biofilm Infection. In: Bjarnsholt T, Jensen P\u00d8, Moser C, H\u00f8iby N (eds) Biofilm infections. Springer, New York, pp 267\u2013290. https:\/\/doi.org\/10.1007\/978-1-4419-6084-9_16"},{"issue":"2","key":"11_CR62","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1574-695X.2012.00977.x","volume":"65","author":"EM Ryan","year":"2012","unstructured":"Ryan EM, Alkawareek MY, Donnelly RF, Gilmore BF (2012) Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. FEMS Immunol Med Microbiol 65(2):395\u2013398. https:\/\/doi.org\/10.1111\/j.1574-695X.2012.00977.x","journal-title":"FEMS Immunol Med Microbiol"},{"key":"11_CR63","first-page":"59","volume":"33","author":"AM Salisbury","year":"2018","unstructured":"Salisbury AM, Woo K, Sarkar S, Schultz G, Malone M, Mayer DO, Percival SL (2018) Tolerance of biofilms to antimicrobials and significance to antibiotic resistance in wounds. Surg Technol Int 33:59\u201366","journal-title":"Surg Technol Int"},{"issue":"2","key":"11_CR64","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/PRS.0b013e31827e47cd","volume":"131","author":"AK Seth","year":"2013","unstructured":"Seth AK, Geringer MR, Nguyen KT, Agnew SP, Dumanian Z, Galiano RD, Leung KP, Mustoe TA, Hong SJ (2013) Bacteriophage therapy for Staphylococcus aureus biofilm-infected wounds: a new approach to chronic wound care. Plast Reconstr Surg 131(2):225\u2013234. https:\/\/doi.org\/10.1097\/PRS.0b013e31827e47cd","journal-title":"Plast Reconstr Surg"},{"key":"11_CR65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1472-6750-8-79","volume":"8","author":"S Sillankorva","year":"2008","unstructured":"Sillankorva S, Neubauer P, Azeredo J (2008) Pseudomonas fluorescens biofilms subjected to phage phiIBB-PF7A. BMC Biotechnol 8:79. https:\/\/doi.org\/10.1186\/1472-6750-8-79","journal-title":"BMC Biotechnol"},{"issue":"4","key":"11_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153777","volume":"11","author":"S Singla","year":"2016","unstructured":"Singla S, Harjai K, Katare OP, Chhibber S (2016) Encapsulation of bacteriophage in liposome accentuates its entry in to macrophage and shields it from neutralizing antibodies. PLoS One 11(4):e0153777. https:\/\/doi.org\/10.1371\/journal.pone.0153777","journal-title":"PLoS One"},{"issue":"9","key":"11_CR67","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1021\/ac300096j","volume":"84","author":"K Sonkar","year":"2012","unstructured":"Sonkar K, Purusottam RN, Sinha N (2012) Metabonomic study of host-phage interaction by nuclear magnetic resonance- and statistical total correlation spectroscopy-based analysis. Anal Chem 84(9):4063\u20134070. https:\/\/doi.org\/10.1021\/ac300096j","journal-title":"Anal Chem"},{"issue":"4","key":"11_CR68","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tim.2015.12.011","volume":"24","author":"C Torres-Barcelo","year":"2016","unstructured":"Torres-Barcelo C, Hochberg ME (2016) Evolutionary rationale for phages as complements of antibiotics. Trends Microbiol 24(4):249\u2013256. https:\/\/doi.org\/10.1016\/j.tim.2015.12.011","journal-title":"Trends Microbiol"},{"issue":"4","key":"11_CR69","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/1040841X.2016.1252312","volume":"43","author":"U Trivedi","year":"2017","unstructured":"Trivedi U, Madsen JS, Rumbaugh KP, Wolcott RD, Burmolle M, Sorensen SJ (2017) A post-planktonic era of in vitro infectious models: issues and changes addressed by a clinically relevant wound like media. Crit Rev Microbiol 43(4):453\u2013465. https:\/\/doi.org\/10.1080\/1040841X.2016.1252312","journal-title":"Crit Rev Microbiol"},{"issue":"6","key":"11_CR70","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1128\/JVI.02763-12","volume":"87","author":"K Vandersteegen","year":"2013","unstructured":"Vandersteegen K, Kropinski AM, Nash JH, Noben JP, Hermans K, Lavigne R (2013) Romulus and Remus, two phage isolates representing a distinct clade within the Twortlikevirus genus, display suitable properties for phage therapy applications. J Virol 87(6):3237\u20133247. https:\/\/doi.org\/10.1128\/JVI.02763-12","journal-title":"J Virol"},{"issue":"6","key":"11_CR71","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/jac\/dkp360","volume":"64","author":"V Verma","year":"2009","unstructured":"Verma V, Harjai K, Chhibber S (2009) Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment. J Antimicrob Chemother 64(6):1212\u20131218. https:\/\/doi.org\/10.1093\/jac\/dkp360","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"11_CR72","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/08927014.2010.511196","volume":"26","author":"V Verma","year":"2010","unstructured":"Verma V, Harjai K, Chhibber S (2010) Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae. Biofouling 26(6):729\u2013737. https:\/\/doi.org\/10.1080\/08927014.2010.511196","journal-title":"Biofouling"},{"issue":"2","key":"11_CR73","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/08927014.2015.1131821","volume":"32","author":"D Vilas Boas","year":"2016","unstructured":"Vilas Boas D, Almeida C, Sillankorva S, Nicolau A, Azeredo J, Azevedo NF (2016) Discrimination of bacteriophage infected cells using locked nucleic acid fluorescent in situ hybridization (LNA-FISH). Biofouling 32(2):179\u2013190. https:\/\/doi.org\/10.1080\/08927014.2015.1131821","journal-title":"Biofouling"},{"issue":"7","key":"11_CR74","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/thoraxjnl-2016-209265","volume":"72","author":"EM Waters","year":"2017","unstructured":"Waters EM, Neill DR, Kaman B, Sahota JS, Clokie MRJ, Winstanley C, Kadioglu A (2017) Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa. Thorax 72(7):666\u2013667. https:\/\/doi.org\/10.1136\/thoraxjnl-2016-209265","journal-title":"Thorax"},{"issue":"4","key":"11_CR75","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1749-4486.2009.01973.x","volume":"34","author":"A Wright","year":"2009","unstructured":"Wright A, Hawkins CH, Anggard EE, Harper DR (2009) A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol 34(4):349\u2013357. https:\/\/doi.org\/10.1111\/j.1749-4486.2009.01973.x","journal-title":"Clin Otolaryngol"},{"issue":"2","key":"11_CR76","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2106\/JBJS.K.01135","volume":"95","author":"C Yilmaz","year":"2013","unstructured":"Yilmaz C, Colak M, Yilmaz BC, Ersoz G, Kutateladze M, Gozlugol M (2013) Bacteriophage therapy in implant-related infections: an experimental study. J Bone Joint Surg Am 95(2):117\u2013125. https:\/\/doi.org\/10.2106\/JBJS.K.01135","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"11_CR77","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/bit.24630","volume":"110","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Hu Z (2013) Combined treatment of Pseudomonas aeruginosa biofilms with bacteriophages and chlorine. Biotechnol Bioeng 110(1):286\u2013295. https:\/\/doi.org\/10.1002\/bit.24630","journal-title":"Biotechnol Bioeng"}],"container-title":["Phage Therapy: A Practical Approach"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-26736-0_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T04:22:11Z","timestamp":1611634931000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-26736-0_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030267353","9783030267360"],"references-count":77,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-26736-0_11","relation":{},"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"26 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}